FOLD - Oversold - Strong buy. PT: $20

Long

Amicus Therapeutics, Inc. (NASDAQ:FOLD)

Updated

NASDAQ:FOLD Amicus Therapeutics, Inc.

trendanalysis fold amicus biotech

RSI indicator showing that FOLD is oversold. A reversal to $18 - $20 is very likely.

For educational purposes only.

Trade active:

Buy: $10.52

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.